SEC Form 4 · accession 0001104659-15-084104
NephroGenex, Inc. · NRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eugen Steiner
Director
Period of report
Dec 9, 2015
Accepted (ET)
Dec 10, 2015 · 6:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001338095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 9, 2015 | A | 76,045 | $0.00 | A | 76,045 | I | By Setraco EHF |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution of shares from the dissolution of BioStratum, Inc., of which the reporting person was a shareholder.